Dennis Ross-Degnan, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deductibles and Coinsurance | 37 | 2023 | 316 | 6.360 |
Why?
|
| Drug Costs | 33 | 2021 | 1176 | 2.640 |
Why?
|
| Health Maintenance Organizations | 25 | 2013 | 658 | 2.590 |
Why?
|
| Cost Sharing | 16 | 2024 | 405 | 2.180 |
Why?
|
| Drug Utilization | 35 | 2020 | 1192 | 2.170 |
Why?
|
| Diabetes Mellitus | 31 | 2024 | 5840 | 2.060 |
Why?
|
| Drug Prescriptions | 37 | 2021 | 1657 | 1.990 |
Why?
|
| Patient Compliance | 17 | 2017 | 2680 | 1.950 |
Why?
|
| Inappropriate Prescribing | 4 | 2021 | 206 | 1.910 |
Why?
|
| Health Expenditures | 28 | 2024 | 2334 | 1.880 |
Why?
|
| Insurance, Health | 31 | 2022 | 2490 | 1.880 |
Why?
|
| Drugs, Essential | 9 | 2020 | 69 | 1.770 |
Why?
|
| Insurance Coverage | 23 | 2020 | 1929 | 1.550 |
Why?
|
| Financing, Personal | 13 | 2020 | 309 | 1.540 |
Why?
|
| Hypoglycemic Agents | 15 | 2024 | 3108 | 1.380 |
Why?
|
| Medicare Part D | 14 | 2021 | 349 | 1.330 |
Why?
|
| Health Policy | 26 | 2020 | 2655 | 1.320 |
Why?
|
| Health Services Accessibility | 23 | 2022 | 5280 | 1.320 |
Why?
|
| Health Benefit Plans, Employee | 4 | 2017 | 334 | 1.260 |
Why?
|
| Community Health Services | 5 | 2020 | 654 | 1.180 |
Why?
|
| Respiratory Tract Infections | 10 | 2021 | 994 | 1.170 |
Why?
|
| Diabetes Complications | 6 | 2024 | 1341 | 1.160 |
Why?
|
| Insurance, Pharmaceutical Services | 17 | 2011 | 345 | 1.120 |
Why?
|
| Developing Countries | 15 | 2022 | 2820 | 1.110 |
Why?
|
| Medicaid | 34 | 2021 | 2793 | 1.050 |
Why?
|
| Poverty | 17 | 2022 | 2638 | 1.050 |
Why?
|
| National Health Programs | 6 | 2019 | 443 | 0.990 |
Why?
|
| Workload | 2 | 2021 | 838 | 0.980 |
Why?
|
| Drug Therapy | 11 | 2014 | 499 | 0.950 |
Why?
|
| Benzodiazepines | 10 | 2015 | 1119 | 0.890 |
Why?
|
| Medication Adherence | 14 | 2021 | 2133 | 0.880 |
Why?
|
| Antihypertensive Agents | 10 | 2019 | 2037 | 0.860 |
Why?
|
| Pharmaceutical Preparations | 6 | 2013 | 1083 | 0.850 |
Why?
|
| Pharmacies | 6 | 2019 | 163 | 0.850 |
Why?
|
| China | 12 | 2023 | 2335 | 0.830 |
Why?
|
| Carbapenems | 1 | 2023 | 121 | 0.820 |
Why?
|
| Medical Savings Accounts | 3 | 2022 | 34 | 0.820 |
Why?
|
| Gastric Bypass | 8 | 2024 | 817 | 0.810 |
Why?
|
| Healthcare Disparities | 8 | 2018 | 3302 | 0.810 |
Why?
|
| Blood Glucose Self-Monitoring | 5 | 2019 | 444 | 0.780 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2024 | 247 | 0.730 |
Why?
|
| Medicare | 24 | 2022 | 6689 | 0.720 |
Why?
|
| Bronchitis | 1 | 2021 | 197 | 0.720 |
Why?
|
| Contraception | 2 | 2021 | 345 | 0.720 |
Why?
|
| Patient Acceptance of Health Care | 12 | 2020 | 3117 | 0.700 |
Why?
|
| Health Personnel | 5 | 2022 | 3270 | 0.690 |
Why?
|
| Emergency Service, Hospital | 15 | 2021 | 7730 | 0.690 |
Why?
|
| Speech Recognition Software | 2 | 2010 | 74 | 0.680 |
Why?
|
| Drug Utilization Review | 10 | 2015 | 250 | 0.670 |
Why?
|
| Humans | 293 | 2024 | 752810 | 0.670 |
Why?
|
| Middle Aged | 132 | 2024 | 217250 | 0.670 |
Why?
|
| Health Care Costs | 15 | 2024 | 3209 | 0.660 |
Why?
|
| Treatment Refusal | 7 | 2013 | 427 | 0.660 |
Why?
|
| Ambulatory Care | 5 | 2017 | 2743 | 0.640 |
Why?
|
| Adult | 123 | 2023 | 217168 | 0.630 |
Why?
|
| Telephone | 4 | 2014 | 623 | 0.630 |
Why?
|
| Frail Elderly | 2 | 2020 | 731 | 0.620 |
Why?
|
| Obesity, Morbid | 7 | 2024 | 1255 | 0.610 |
Why?
|
| Delayed Diagnosis | 2 | 2019 | 452 | 0.610 |
Why?
|
| Female | 169 | 2024 | 386339 | 0.600 |
Why?
|
| Diabetes Mellitus, Type 2 | 14 | 2024 | 12154 | 0.600 |
Why?
|
| Bipolar Disorder | 10 | 2022 | 5069 | 0.590 |
Why?
|
| Family Characteristics | 6 | 2016 | 989 | 0.590 |
Why?
|
| Appointments and Schedules | 4 | 2020 | 429 | 0.590 |
Why?
|
| Mammography | 5 | 2022 | 2434 | 0.590 |
Why?
|
| Early Detection of Cancer | 6 | 2020 | 3163 | 0.570 |
Why?
|
| Guideline Adherence | 7 | 2014 | 2274 | 0.560 |
Why?
|
| Anti-Bacterial Agents | 11 | 2023 | 7294 | 0.550 |
Why?
|
| Reimbursement Mechanisms | 11 | 2021 | 662 | 0.550 |
Why?
|
| United States | 90 | 2024 | 71434 | 0.540 |
Why?
|
| Program Evaluation | 8 | 2020 | 2464 | 0.530 |
Why?
|
| Health Care Reform | 6 | 2016 | 1242 | 0.520 |
Why?
|
| Patient Readmission | 7 | 2020 | 3288 | 0.520 |
Why?
|
| Nonprescription Drugs | 1 | 2016 | 117 | 0.510 |
Why?
|
| Diarrhea | 4 | 2014 | 1335 | 0.510 |
Why?
|
| Hypolipidemic Agents | 3 | 2017 | 621 | 0.510 |
Why?
|
| Male | 142 | 2024 | 355160 | 0.510 |
Why?
|
| Health Services Research | 11 | 2015 | 1809 | 0.510 |
Why?
|
| Breast Neoplasms | 15 | 2022 | 20844 | 0.510 |
Why?
|
| Chronic Disease | 14 | 2021 | 9174 | 0.510 |
Why?
|
| Fees, Pharmaceutical | 6 | 2011 | 66 | 0.510 |
Why?
|
| Medical Indigency | 4 | 2011 | 63 | 0.500 |
Why?
|
| Length of Stay | 8 | 2017 | 6372 | 0.490 |
Why?
|
| Mass Screening | 6 | 2017 | 5395 | 0.490 |
Why?
|
| Antidepressive Agents | 9 | 2017 | 2871 | 0.480 |
Why?
|
| Aged | 92 | 2024 | 166705 | 0.470 |
Why?
|
| Quality Assurance, Health Care | 6 | 2018 | 2171 | 0.470 |
Why?
|
| Anti-Anxiety Agents | 3 | 2007 | 395 | 0.470 |
Why?
|
| Malaria | 3 | 2014 | 1207 | 0.460 |
Why?
|
| Continuity of Patient Care | 3 | 2017 | 1050 | 0.460 |
Why?
|
| Longitudinal Studies | 23 | 2021 | 14323 | 0.450 |
Why?
|
| Vulnerable Populations | 2 | 2019 | 694 | 0.450 |
Why?
|
| Medication Therapy Management | 1 | 2014 | 130 | 0.440 |
Why?
|
| Patient Protection and Affordable Care Act | 8 | 2022 | 1187 | 0.440 |
Why?
|
| Cluster Analysis | 5 | 2014 | 2683 | 0.440 |
Why?
|
| Gastrectomy | 7 | 2024 | 664 | 0.440 |
Why?
|
| Preventive Medicine | 1 | 2015 | 252 | 0.430 |
Why?
|
| Adolescent | 56 | 2021 | 86822 | 0.430 |
Why?
|
| Private Practice | 2 | 2004 | 153 | 0.430 |
Why?
|
| Patient Admission | 4 | 2017 | 1375 | 0.430 |
Why?
|
| Young Adult | 40 | 2021 | 57732 | 0.430 |
Why?
|
| Socioeconomic Factors | 22 | 2017 | 7746 | 0.420 |
Why?
|
| Hospitalization | 14 | 2021 | 10628 | 0.420 |
Why?
|
| Postnatal Care | 5 | 2016 | 255 | 0.420 |
Why?
|
| Regression Analysis | 10 | 2016 | 6363 | 0.420 |
Why?
|
| Gastrointestinal Diseases | 4 | 2011 | 1176 | 0.410 |
Why?
|
| Sexual Behavior | 2 | 2019 | 2062 | 0.410 |
Why?
|
| Suicide, Attempted | 1 | 2020 | 1242 | 0.400 |
Why?
|
| Insurance Claim Review | 13 | 2021 | 735 | 0.400 |
Why?
|
| Health Care Surveys | 12 | 2013 | 2427 | 0.390 |
Why?
|
| Quality Control | 1 | 2014 | 825 | 0.390 |
Why?
|
| Heart Diseases | 2 | 2024 | 2790 | 0.390 |
Why?
|
| Quality of Health Care | 15 | 2018 | 4343 | 0.390 |
Why?
|
| Cost of Illness | 5 | 2019 | 1911 | 0.380 |
Why?
|
| Cross-Sectional Studies | 25 | 2021 | 25540 | 0.380 |
Why?
|
| Acute Disease | 5 | 2016 | 7217 | 0.380 |
Why?
|
| Massachusetts | 22 | 2016 | 8706 | 0.370 |
Why?
|
| Prescription Fees | 6 | 2014 | 150 | 0.370 |
Why?
|
| Public Sector | 3 | 2011 | 263 | 0.370 |
Why?
|
| Cohort Studies | 34 | 2024 | 40996 | 0.360 |
Why?
|
| Income | 7 | 2021 | 1864 | 0.350 |
Why?
|
| Primary Health Care | 9 | 2023 | 4617 | 0.350 |
Why?
|
| Legislation, Drug | 4 | 2007 | 211 | 0.350 |
Why?
|
| Social Class | 4 | 2015 | 1992 | 0.340 |
Why?
|
| Commerce | 5 | 2020 | 595 | 0.340 |
Why?
|
| Colorectal Neoplasms | 4 | 2016 | 6793 | 0.340 |
Why?
|
| Evaluation Studies as Topic | 1 | 2011 | 1634 | 0.330 |
Why?
|
| Philippines | 4 | 2020 | 88 | 0.330 |
Why?
|
| Health Surveys | 7 | 2013 | 4014 | 0.330 |
Why?
|
| Physicians | 6 | 2021 | 4550 | 0.330 |
Why?
|
| Data Collection | 9 | 2010 | 3302 | 0.330 |
Why?
|
| Confidence Intervals | 5 | 2013 | 2937 | 0.320 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2017 | 1898 | 0.320 |
Why?
|
| Retrospective Studies | 42 | 2024 | 79160 | 0.320 |
Why?
|
| Community-Institutional Relations | 1 | 2010 | 206 | 0.310 |
Why?
|
| Drugs, Generic | 4 | 2019 | 444 | 0.310 |
Why?
|
| Policy Making | 3 | 2011 | 538 | 0.310 |
Why?
|
| Insurance, Hospitalization | 1 | 2007 | 30 | 0.290 |
Why?
|
| Midwifery | 1 | 2009 | 123 | 0.290 |
Why?
|
| Brazil | 6 | 2020 | 1185 | 0.290 |
Why?
|
| Antipsychotic Agents | 8 | 2022 | 3049 | 0.290 |
Why?
|
| Insurance Benefits | 3 | 2015 | 183 | 0.280 |
Why?
|
| Patient Discharge | 6 | 2020 | 3411 | 0.280 |
Why?
|
| Drug Industry | 8 | 2018 | 780 | 0.280 |
Why?
|
| Anti-Retroviral Agents | 3 | 2013 | 1771 | 0.270 |
Why?
|
| Interviews as Topic | 10 | 2018 | 2619 | 0.270 |
Why?
|
| Hypertension | 9 | 2020 | 8497 | 0.270 |
Why?
|
| Insulin | 5 | 2024 | 6566 | 0.260 |
Why?
|
| Costs and Cost Analysis | 7 | 2021 | 1674 | 0.260 |
Why?
|
| Respiratory Tract Diseases | 1 | 2011 | 745 | 0.260 |
Why?
|
| Aftercare | 2 | 2020 | 914 | 0.260 |
Why?
|
| Mental Health | 1 | 2020 | 3150 | 0.260 |
Why?
|
| Health Services Needs and Demand | 2 | 2013 | 1392 | 0.260 |
Why?
|
| Electronic Health Records | 3 | 2020 | 4630 | 0.260 |
Why?
|
| Delivery of Health Care | 10 | 2019 | 5277 | 0.260 |
Why?
|
| Models, Statistical | 2 | 2011 | 5053 | 0.260 |
Why?
|
| Multivariate Analysis | 12 | 2015 | 12138 | 0.250 |
Why?
|
| Antineoplastic Agents | 7 | 2021 | 13558 | 0.250 |
Why?
|
| Prenatal Care | 2 | 2011 | 1104 | 0.250 |
Why?
|
| Economic Recession | 3 | 2014 | 79 | 0.250 |
Why?
|
| Nicaragua | 2 | 2015 | 29 | 0.250 |
Why?
|
| Honduras | 2 | 2015 | 37 | 0.250 |
Why?
|
| Residence Characteristics | 5 | 2018 | 2019 | 0.250 |
Why?
|
| Prescriptions | 2 | 2008 | 385 | 0.250 |
Why?
|
| Managed Care Programs | 3 | 2008 | 935 | 0.240 |
Why?
|
| Logistic Models | 14 | 2020 | 13277 | 0.240 |
Why?
|
| Cost Control | 11 | 2014 | 626 | 0.240 |
Why?
|
| Uganda | 6 | 2014 | 1308 | 0.240 |
Why?
|
| New Jersey | 9 | 2007 | 289 | 0.240 |
Why?
|
| Severity of Illness Index | 4 | 2011 | 15695 | 0.240 |
Why?
|
| Guatemala | 2 | 2015 | 156 | 0.240 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2014 | 1992 | 0.230 |
Why?
|
| Occult Blood | 3 | 2016 | 194 | 0.230 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 2 | 2003 | 41 | 0.230 |
Why?
|
| Age Factors | 12 | 2019 | 18302 | 0.220 |
Why?
|
| Time Factors | 17 | 2019 | 39885 | 0.220 |
Why?
|
| Jaundice, Neonatal | 1 | 2004 | 72 | 0.220 |
Why?
|
| Hospital Costs | 2 | 2015 | 972 | 0.220 |
Why?
|
| Eligibility Determination | 4 | 2020 | 405 | 0.220 |
Why?
|
| Africa, Eastern | 4 | 2013 | 73 | 0.220 |
Why?
|
| Penicillins | 2 | 2023 | 398 | 0.220 |
Why?
|
| Hospitals, District | 1 | 2004 | 113 | 0.220 |
Why?
|
|